Vaccine Adjuvants Market Share, Size, Trends, Industry Analysis Report, By Product Type (Mineral Salt-based Adjuvant, Tensoactive Adjuvants, Adjuvant Emulsions, Liposome Adjuvants, Carbohydrate Adjuvants, Bacteria-derived Adjuvants, Virus-like Particles (

Vaccine Adjuvants Market Share, Size, Trends, Industry Analysis Report, By Product Type (Mineral Salt-based Adjuvant, Tensoactive Adjuvants, Adjuvant Emulsions, Liposome Adjuvants, Carbohydrate Adjuvants, Bacteria-derived Adjuvants, Virus-like Particles (VLP), and Other Types); By Route of Administration (Oral, Subcutaneous, Intranasal, Intramuscular, Intradermal, and Others); By Disease Types; By Application (Research Application and Commercial Application), By Regions; Segment Forecast, 2024 –2032



The global Vaccine Adjuvants Market size is expected to reach USD 1,505.58 million by 2032 according to a new study by Polaris Market Research. The report “Vaccine Adjuvants Market Share, Size, Trends, Industry Analysis Report, By Product Type (Mineral Salt-based, Tensoactive, Emulsions, Liposome, Carbohydrate, Bacteria-derived, Virus-like Particles (VLP), and Other Adjuvants); By Route of Administration (Oral, Subcutaneous, Intranasal, Intramuscular, Intradermal, and Others); By Disease Types (Infectious Diseases, Rare Diseases, Cancer, Autoimmune Disorders, and Others); By Application (Research Application and Commercial Application), By Regions; Segment Forecast, 2024 –2032” gives a detailed insight into current market dynamics and provides analysis on future market growth.

Adjuvant is defined as a substance which in combination with vaccine invigorates antigen specific immune reactions to increase specificity and immunogenicity of marketed vaccines administered in any individual. Adjuvants augment the impact of a vaccine providing increased immunity towards any particular infectious disease. It triggers positive immune response by mimicking pathogen associated molecular pattern (PAMP), which include lipo-polysaccharide, liposomes, cell walls of bacteria, and endo-cytosed and un-methylated nucleic acids. Adjuvant imparts beneficial effects to vaccines in several ways such as increasing its potency to grasp the higher degree of immunogenicity, reducing the number of repeated vaccinations, antigen dose reduction, widening antibody responses of the individual, and inducing T-cell responses.

The global market is driven by the recent surge in infectious diseases, extensive research on vaccines, and funding from the government. European Union (EU) through EU programme Horizon 2020, has formed ENOVA, a network on vaccine adjuvants. This will bring both industry experts and stakeholders working in the areas of vaccine research and development and adjuvant research to reduce side effects and efficacy of new developing vaccines.

Market participants such as GlaxoSmithKline Plc, Novavax, Inc., Statens Serum Institut, Viscogel AB, VaxLiant LLC, Aphios Corporation, Moderna Inc., Sanofi Pasteur, Adjuvatis, Avanti Polar Lipids, Inc., MPV Technologies, CSL Limited, Vaxine Pty Ltd, SPI Pharma, CureVac AG, Sergeant Adjuvants, Agenus, Inc., OZ Biosciences, Adjuvants Unlimited Inc., and Adjuvants Euclid Canada Inc. are some of the key players operating in the concerned market.

To speed up the process of nCOV vaccine development big players are collaborating with industry stakeholders. In February 2020, GSK and Coalition for Epidemic Preparedness Innovations (CEPI) collaborated to ease the out nCOV vaccine development with GSK’s vaccine adjuvant platform for other players in vaccine development. Similarly, in March 2020, iBio, a contract research organization (CRO) signed a definitive agreement with the Infectious Disease Research Institute (IDRI). The combination of iBio’s VLP antigen with the latter adjuvant expected to offer promising efficacy and safety characteristics.

Polaris Market research has segmented the Vaccine Adjuvants Market report on the basis of product type, route of administration, disease type, application, and region

Vaccine Adjuvant Product Type Outlook (Revenue - USD Million, 2016 – 2027)

- Mineral Salt-based Adjuvant

- Tensoactive Adjuvants

- Adjuvant Emulsions

- Liposome Adjuvants

- Carbohydrate Adjuvants

- Bacteria-derived Adjuvants

- Virus-like Particles (VLP)

- Other Types

Vaccine Adjuvant Route of Administration Outlook (Revenue - USD Million, 2016 – 2027)

- Oral

- Subcutaneous

- Intranasal

- Intramuscular

- Intradermal

- Others

Vaccine Adjuvant Disease Type Outlook (Revenue - USD Million, 2016 – 2027)

- Infectious Diseases

- Rare Diseases

- Cancer

- Autoimmune Disorders

- Others

Vaccine Adjuvant Application Outlook (Revenue - USD Million, 2016 – 2027)

- Research Application

- Commercial Application

Vaccine Adjuvant Regional Outlook (Revenue - USD Million, 2016 – 2027)

- North America

U.S.

Canada

- Europe

France

Germany

UK

Italy

Spain

Belgium

Austria

- Asia Pacific

China

India

Japan

Malaysia

Australia

South Korea

- Central & South America

Mexico

Brazil

Argentina

- Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa


1. Introduction
1. Report Description
1. Objectives of the Study
2. Market Scope
3. Assumptions
2. Stakeholders
2. Executive Summary
1. Market Highlights
3. Research Methodology
1. Overview
1. Data Mining
2. Data Sources
1. Primary Sources
2. Secondary Sources
4. Vaccine Adjuvants Market Insights
1. Vaccine Adjuvant – Industry snapshot
2. Vaccine Adjuvants Market Dynamics
1. Drivers and Opportunities
1. Surge in the infectious diseases
2. Government sponsored immunization programs
2. Restraints and Challenges
1. Side effects associated with the usage of adjuvants
3. Porter’s Five Forces Analysis
1. Bargaining Power of Suppliers (Moderate)
2. Threats of New Entrants: (Low)
3. Bargaining Power of Buyers (Moderate)
4. Threat of Substitute (Moderate)
5. Rivalry among existing firms (High)
4. PESTLE Analysis
5. Vaccine Adjuvants Market Industry trends
5. Vaccine Adjuvants Market Assessment by Product Type
1. Key Findings
2. Introduction
1. Global Vaccine Adjuvants Market, By Product Type, 2016 - 2027 (USD Million)
3. Mineral Salt-based Adjuvant
1. Global Vaccine Adjuvants Market, by Mineral Salt-based Adjuvant, by Region, 2016- 2027 (USD Million)
4. Tensoactive Adjuvants
1. Global Vaccine Adjuvants Market, by Tensoactive Adjuvants, by Region, 2016- 2027 (USD Million)
5. Adjuvant Emulsions
1. Global Vaccine Adjuvants Market, by Adjuvant Emulsions, by Region, 2016- 2027 (USD Million)
6. Liposome Adjuvants
1. Global Vaccine Adjuvants Market, by Liposome Adjuvants, by Region, 2016- 2027 (USD Million)
7. Carbohydrate Adjuvants
1. Global Vaccine Adjuvants Market, by Carbohydrate Adjuvants, by Region, 2016- 2027 (USD Million)
8. Bacteria-derived Adjuvants
1. Global Vaccine Adjuvants Market, by Bacteria-derived Adjuvants, by Region, 2016- 2027 (USD Million)
9. Virus-like Particles (VLP)
1. Global Vaccine Adjuvants Market, by Virus-like Particles (VLP), by Region, 2016- 2027 (USD Million)
10. Other Types
1. Global Vaccine Adjuvants Market, by Other Types, by Region, 2016- 2027 (USD Million)
6. Global Vaccine Adjuvants Market, by Route of Administration
1. Key Findings
2. Introduction
1. Global Vaccine Adjuvants Market, By Route of Administration, 2016 - 2027 (USD Million)
3. Oral
1. Global Vaccine Adjuvants Market, by Oral, By Region, 2016- 2027 (USD Million)
4. Subcutaneous
1. Global Vaccine Adjuvants Market, by subcutaneous, by Region, 2016- 2027 (USD Million)
5. Intranasal
1. Global Vaccine Adjuvants Market, by Intranasal, by Region, 2016- 2027 (USD Million)
6. Intramuscular
1. Global Vaccine Adjuvants Market, by Intramuscular, by Region, 2016- 2027 (USD Million)
7. Intradermal
1. Global Vaccine Adjuvants Market, by Intradermal, by Region, 2016- 2027 (USD Million)
8. Others
1. Global Vaccine Adjuvants Market, by Others, by Region, 2016- 2027 (USD Million)
7. Global Vaccine Adjuvants Market, by Disease Type
1. Key Findings
2. Introduction
1. Global Vaccine Adjuvants Market, By Disease Type, 2016 - 2027 (USD Million)
3. Infectious Diseases
1. Global Vaccine Adjuvants Market, by Infectious Diseases, By Region, 2016- 2027 (USD Million)
4. Rare Diseases
1. Global Vaccine Adjuvants Market, by Rare Diseases, by Region, 2016- 2027 (USD Million)
5. Cancer
1. Global Vaccine Adjuvants Market, by Cancer, by Region, 2016- 2027 (USD Million)
6. Autoimmune Disorders
1. Global Vaccine Adjuvants Market, by Autoimmune Disorders, by Region, 2016- 2027 (USD Million)
7. Others
1. Global Vaccine Adjuvants Market, by Others, by Region, 2016- 2027 (USD Million)
8. Vaccine Adjuvants Market Assessment by Application
1. Key Findings
2. Introduction
1. Global Vaccine Adjuvants Market, By Application, 2016 - 2027 (USD Million)
3. Research Application
1. Global Vaccine Adjuvants Market, by Research Application, by Region, 2016- 2027 (USD Million)
4. Commercial Application
1. Global Vaccine Adjuvants Market, by Commercial Application, by Region, 2016- 2027 (USD Million)
9. Vaccine Adjuvants Market Assessment by Geography
1. Key findings
2. Introduction
1. Vaccine Adjuvants Market Assessment, By Geography, 2016- 2027 (USD Million)
3. Vaccine Adjuvants Market – North America
1. North America: Vaccine Adjuvants Market, By Product Type, 2016- 2027 (USD Million)
2. North America: Vaccine Adjuvants Market, By Route of Administration, 2016- 2027 (USD Million)
3. North America: Vaccine Adjuvants Market, By Disease Type, 2016 - 2027 (USD Million)
4. North America: Vaccine Adjuvants Market, By Application, 2016- 2027 (USD Million)
5. Vaccine Adjuvants Market – U.S.
1. U.S.: Vaccine Adjuvants Market, By Product Type, 2016- 2027 (USD Million)
2. U.S.: Vaccine Adjuvants Market, By Route of Administration, 2016- 2027 (USD Million)
3. U.S.: Vaccine Adjuvants Market, By Disease Type, 2016- 2027 (USD Million)
4. U.S.: Vaccine Adjuvants Market, By Application, 2016- 2027 (USD Million)
6. Vaccine Adjuvants Market – Canada
1. Canada: Vaccine Adjuvants Market, By Product Type, 2016- 2027 (USD Million)
2. Canada.: Vaccine Adjuvants Market, By Route of Administration, 2016- 2027 (USD Million)
3. Canada: Vaccine Adjuvants Market, By Disease Type, 2016- 2027 (USD Million)
4. Canada: Vaccine Adjuvants Market, By Application, 2016- 2027 (USD Million)
4. Vaccine Adjuvants Market – Europe
1. Europe: Vaccine Adjuvants Market, By Product Type, 2016- 2027 (USD Million)
2. Europe.: Vaccine Adjuvants Market, By Route of Administration, 2016- 2027 (USD Million)
3. Europe: Vaccine Adjuvants Market, By Disease Type, 2016- 2027 (USD Million)
4. Europe: Vaccine Adjuvants Market, By Application, 2016- 2027 (USD Million)
5. Vaccine Adjuvants Market – UK
1. UK: Vaccine Adjuvants Market, By Product Type, 2016- 2027 (USD Million)
2. UK.: Vaccine Adjuvants Market, By Route of Administration, 2016- 2027 (USD Million)
3. UK: Vaccine Adjuvants Market, By Disease Type, 2016- 2027 (USD Million)
4. UK: Vaccine Adjuvants Market, By Application, 2016- 2027 (USD Million)
6. Vaccine Adjuvants Market – France
1. France: Vaccine Adjuvants Market, By Product Type, 2016- 2027 (USD Million)
2. France.: Vaccine Adjuvants Market, By Route of Administration, 2016- 2027 (USD Million)
3. France: Vaccine Adjuvants Market, By Disease Type, 2016- 2027 (USD Million)
4. France: Vaccine Adjuvants Market, By Application, 2016- 2027 (USD Million)
7. Vaccine Adjuvants Market – Germany
1. Germany: Vaccine Adjuvants Market, By Product Type, 2016- 2027 (USD Million)
2. Germany.: Vaccine Adjuvants Market, By Route of Administration, 2016- 2027 (USD Million)
3. Germany: Vaccine Adjuvants Market, By Disease Type, 2016- 2027 (USD Million)
4. Germany: Vaccine Adjuvants Market, By Application, 2016- 2027 (USD Million)
8. Vaccine Adjuvants Market – Italy
1. Italy: Vaccine Adjuvants Market, By Product Type, 2016- 2027 (USD Million)
2. Italy.: Vaccine Adjuvants Market, By Route of Administration, 2016- 2027 (USD Million)
3. Italy: Vaccine Adjuvants Market, By Disease Type, 2016- 2027 (USD Million)
4. Italy: Vaccine Adjuvants Market, By Application, 2016- 2027 (USD Million)
9. Vaccine Adjuvants Market – Spain
1. Spain: Vaccine Adjuvants Market, By Product Type, 2016- 2027 (USD Million)
2. Spain.: Vaccine Adjuvants Market, By Route of Administration, 2016- 2027 (USD Million)
3. Spain: Vaccine Adjuvants Market, By Disease Type, 2016- 2027 (USD Million)
4. Spain: Vaccine Adjuvants Market, By Application, 2016- 2027 (USD Million)
10. Vaccine Adjuvants Market – Belgium
1. Belgium: Vaccine Adjuvants Market, By Product Type, 2016- 2027 (USD Million)
2. Belgium.: Vaccine Adjuvants Market, By Route of Administration, 2016- 2027 (USD Million)
3. Belgium: Vaccine Adjuvants Market, By Disease Type, 2016- 2027 (USD Million)
4. Belgium: Vaccine Adjuvants Market, By Application, 2016- 2027 (USD Million)
11. Vaccine Adjuvants Market – Austria
1. Austria: Vaccine Adjuvants Market, By Product Type, 2016- 2027 (USD Million)
2. Austria.: Vaccine Adjuvants Market, By Route of Administration, 2016- 2027 (USD Million)
3. Austria: Vaccine Adjuvants Market, By Disease Type, 2016- 2027 (USD Million)
4. Austria: Vaccine Adjuvants Market, By Application, 2016- 2027 (USD Million)
5. Vaccine Adjuvants Market – Asia-Pacific
1. Asia Pacific: Vaccine Adjuvants Market, By Product Type, 2016- 2027 (USD Million)
2. Asia Pacific.: Vaccine Adjuvants Market, By Route of Administration, 2016- 2027 (USD Million)
3. Asia-pacific: Vaccine Adjuvants Market, By Disease Type, 2016- 2027 (USD Million)
4. Asia-pacific: Vaccine Adjuvants Market, By Application, 2016- 2027 (USD Million)
5. Vaccine Adjuvants Market – China
1. China: Vaccine Adjuvants Market, By Product Type, 2016- 2027 (USD Million)
2. China.: Vaccine Adjuvants Market, By Route of Administration, 2016- 2027 (USD Million)
3. China: Vaccine Adjuvants Market, By Disease Type, 2016- 2027 (USD Million)
4. China: Vaccine Adjuvants Market, By Application, 2016- 2027 (USD Million)
6. Vaccine Adjuvants Market – India
1. India: Vaccine Adjuvants Market, By Product Type, 2016- 2027 (USD Million)
2. India.: Vaccine Adjuvants Market, By Route of Administration, 2016- 2027 (USD Million)
3. India: Vaccine Adjuvants Market, By Disease Type, 2016- 2027 (USD Million)
4. India: Vaccine Adjuvants Market, By Application, 2016- 2027 (USD Million)
7. Vaccine Adjuvants Market – Malaysia
1. Malaysia: Vaccine Adjuvants Market, By Product Type, 2016- 2027 (USD Million)
2. Malaysia.: Vaccine Adjuvants Market, By Route of Administration, 2016- 2027 (USD Million)
3. Malaysia: Vaccine Adjuvants Market, By Disease Type, 2016- 2027 (USD Million)
4. Malaysia: Vaccine Adjuvants Market, By Application, 2016- 2027 (USD Million)
8. Vaccine Adjuvants Market – Japan
1. Japan: Vaccine Adjuvants Market, By Product Type, 2016- 2027 (USD Million)
2. Japan.: Vaccine Adjuvants Market, By Route of Administration, 2016- 2027 (USD Million)
3. Japan: Vaccine Adjuvants Market, By Disease Type, 2016- 2027 (USD Million)
4. Japan: Vaccine Adjuvants Market, By Application, 2016- 2027 (USD Million)
9. Vaccine Adjuvants Market – South Korea
1. South Korea: Vaccine Adjuvants Market, By Product Type, 2016- 2027 (USD Million)
2. South Korea.: Vaccine Adjuvants Market, By Route of Administration, 2016- 2027 (USD Million)
3. South Korea: Vaccine Adjuvants Market, By Disease Type, 2016- 2027 (USD Million)
4. South Korea: Vaccine Adjuvants Market, By Application, 2016- 2027 (USD Million)
10. Vaccine Adjuvants Market – Australia
1. Australia: Vaccine Adjuvants Market, By Product Type, 2016- 2027 (USD Million)
2. Australia.: Vaccine Adjuvants Market, By Route of Administration, 2016- 2027 (USD Million)
3. Australia: Vaccine Adjuvants Market, By Disease Type, 2016- 2027 (USD Million)
4. Australia: Vaccine Adjuvants Market, By Application, 2016- 2027 (USD Million)
6. Vaccine Adjuvants Market – Middle East & Africa
1. Middle East & Africa: Vaccine Adjuvants Market, By Product Type, 2016- 2027 (USD Million)
2. Middle East & Africa.: Vaccine Adjuvants Market, By Route of Administration, 2016- 2027 (USD Million)
3. Middle East & Africa: Vaccine Adjuvants Market, By Disease Type, 2016- 2027 (USD Million)
4. Middle East & Africa: Vaccine Adjuvants Market, By Application, 2016- 2027 (USD Million)
5. Vaccine Adjuvants Market – Saudi Arabia
1. Saudi Arabia: Vaccine Adjuvants Market, By Product Type, 2016- 2027 (USD Million)
2. Saudi Arabia.: Vaccine Adjuvants Market, By Route of Administration, 2016- 2027 (USD Million)
3. Saudi Arabia: Vaccine Adjuvants Market, By Disease Type, 2016- 2027 (USD Million)
4. Saudi Arabia: Vaccine Adjuvants Market, By Application, 2016- 2027 (USD Million)
6. Vaccine Adjuvants Market – UAE
1. UAE: Vaccine Adjuvants Market, By Product Type, 2016- 2027 (USD Million)
2. UAE.: Vaccine Adjuvants Market, By Route of Administration, 2016- 2027 (USD Million)
3. UAE: Vaccine Adjuvants Market, By Disease Type, 2016- 2027 (USD Million)
4. UAE: Vaccine Adjuvants Market, By Application, 2016- 2027 (USD Million)
7. Vaccine Adjuvants Market – Israel
1. Israel: Vaccine Adjuvants Market, By Product Type, 2016- 2027 (USD Million)
2. Israel.: Vaccine Adjuvants Market, By Route of Administration, 2016- 2027 (USD Million)
3. Israel: Vaccine Adjuvants Market, By Disease Type, 2016- 2027 (USD Million)
4. Israel: Vaccine Adjuvants Market, By Application, 2016- 2027 (USD Million)
8. Vaccine Adjuvants Market – South Africa
1. South Africa: Vaccine Adjuvants Market, By Product Type, 2016- 2027 (USD Million)
2. South Africa.: Vaccine Adjuvants Market, By Route of Administration, 2016- 2027 (USD Million)
3. South Africa: Vaccine Adjuvants Market, By Disease Type, 2016- 2027 (USD Million)
4. South Africa: Vaccine Adjuvants Market, By Application, 2016- 2027 (USD Million)
7. Vaccine Adjuvants Market – Latin America
1. Latin America: Vaccine Adjuvants Market, By Product Type, 2016- 2027 (USD Million)
2. Latin America.: Vaccine Adjuvants Market, By Route of Administration, 2016- 2027 (USD Million)
3. Latin America: Vaccine Adjuvants Market, By Disease Type, 2016- 2027 (USD Million)
4. Latin America: Vaccine Adjuvants Market, By Application, 2016- 2027 (USD Million)
5. Vaccine Adjuvants Market – Mexico
1. Mexico: Vaccine Adjuvants Market, By Product Type, 2016- 2027 (USD Million)
2. Mexico.: Vaccine Adjuvants Market, By Route of Administration, 2016- 2027 (USD Million)
3. Mexico: Vaccine Adjuvants Market, By Disease Type, 2016- 2027 (USD Million)
4. Mexico: Vaccine Adjuvants Market, By Application, 2016- 2027 (USD Million)
6. Vaccine Adjuvants Market – Brazil
1. Brazil: Vaccine Adjuvants Market, By Product Type, 2016- 2027 (USD Million)
2. Brazil.: Vaccine Adjuvants Market, By Route of Administration, 2016- 2027 (USD Million)
3. Brazil: Vaccine Adjuvants Market, By Disease Type, 2016- 2027 (USD Million)
4. Brazil: Vaccine Adjuvants Market, By Application, 2016- 2027 (USD Million)
7. Vaccine Adjuvants Market – Argentina
1. Argentina: Vaccine Adjuvants Market, By Product Type, 2016- 2027 (USD Million)
2. Argentina.: Vaccine Adjuvants Market, By Route of Administration, 2016- 2027 (USD Million)
3. Argentina: Vaccine Adjuvants Market, By Disease Type, 2016- 2027 (USD Million)
4. Argentina: Vaccine Adjuvants Market, By Application, 2016- 2027 (USD Million)
10. Competitive Landscape
1. Expansion and Acquisition Analysis
1. Expansion
2. Acquisitions
2. Partnerships/Collaborations/Agreements/Exhibitions
11. Company Profiles
1. GlaxoSmithKline Plc
1. Company Overview
2. Product Benchmarking
3. Financial Performance
4. Recent Development
2. Moderna Inc.
1. Company Overview
2. Product Benchmarking
3. Financial Performance
4. Recent Development
3. Sanofi Pasteur
1. Company Overview
2. Product Benchmarking
3. Financial Performance
4. Recent Development
4. Adjuvatis
1. Company Overview
2. Product Benchmarking
3. Financial Performance
4. Recent Development
5. SPI Pharma
1. Company Overview
2. Product Benchmarking
3. Financial Performance
4. Recent Development
6. Novavax, Inc.
1. Company Overview
2. Product Benchmarking
3. Financial Performance
4. Recent Development
7. Sergeant Adjuvants
1. Company Overview
2. Product Benchmarking
3. Financial Performance
4. Recent Development
8. OZ Biosciences
1. Company Overview
2. Product Benchmarking
3. Financial Performance
4. Recent Development
9. Adjuvants Euclid Canada Inc.
1. Company Overview
2. Product Benchmarking
3. Financial Performance
4. Recent Development
10. Adjuvants Unlimited Inc.
1. Company Overview
2. Product Benchmarking
3. Financial Performance
4. Recent Development
11. Aphios Corporation
1. Company Overview
2. Product Benchmarking
3. Financial Performance
4. Recent Development

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings